Cargando…
Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies
Best vitelliform macular dystrophy (BD), autosomal dominant vitreoretinochoroidopathy (ADVIRC), and the autosomal recessive bestrophinopathy (ARB), together known as the bestrophinopathies, are caused by mutations in the bestrophin-1 (BEST1) gene affecting anion transport through the plasma membrane...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084480/ https://www.ncbi.nlm.nih.gov/pubmed/32111077 http://dx.doi.org/10.3390/ijms21051597 |
_version_ | 1783508731533721600 |
---|---|
author | Nachtigal, Anna-Lena Milenkovic, Andrea Brandl, Caroline Schulz, Heidi L. Duerr, Lisa M. J. Lang, Gabriele E. Reiff, Charlotte Herrmann, Philipp Kellner, Ulrich Weber, Bernhard H.F. |
author_facet | Nachtigal, Anna-Lena Milenkovic, Andrea Brandl, Caroline Schulz, Heidi L. Duerr, Lisa M. J. Lang, Gabriele E. Reiff, Charlotte Herrmann, Philipp Kellner, Ulrich Weber, Bernhard H.F. |
author_sort | Nachtigal, Anna-Lena |
collection | PubMed |
description | Best vitelliform macular dystrophy (BD), autosomal dominant vitreoretinochoroidopathy (ADVIRC), and the autosomal recessive bestrophinopathy (ARB), together known as the bestrophinopathies, are caused by mutations in the bestrophin-1 (BEST1) gene affecting anion transport through the plasma membrane of the retinal pigment epithelium (RPE). To date, while no treatment exists a better understanding of BEST1-related pathogenesis may help to define therapeutic targets. Here, we systematically characterize functional consequences of mutant BEST1 in thirteen RPE patient cell lines differentiated from human induced pluripotent stem cells (hiPSCs). Both BD and ARB hiPSC-RPEs display a strong reduction of BEST1-mediated anion transport function compared to control, while ADVIRC mutations trigger an increased anion permeability suggesting a stabilized open state condition of channel gating. Furthermore, BD and ARB hiPSC-RPEs differ by the degree of mutant protein turnover and by the site of subcellular protein quality control with adverse effects on lysosomal pH only in the BD-related cell lines. The latter finding is consistent with an altered processing of catalytic enzymes in the lysosomes. The present study provides a deeper insight into distinct molecular mechanisms of the three bestrophinopathies facilitating functional categorization of the more than 300 known BEST1 mutations that result into the distinct retinal phenotypes. |
format | Online Article Text |
id | pubmed-7084480 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70844802020-03-24 Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies Nachtigal, Anna-Lena Milenkovic, Andrea Brandl, Caroline Schulz, Heidi L. Duerr, Lisa M. J. Lang, Gabriele E. Reiff, Charlotte Herrmann, Philipp Kellner, Ulrich Weber, Bernhard H.F. Int J Mol Sci Article Best vitelliform macular dystrophy (BD), autosomal dominant vitreoretinochoroidopathy (ADVIRC), and the autosomal recessive bestrophinopathy (ARB), together known as the bestrophinopathies, are caused by mutations in the bestrophin-1 (BEST1) gene affecting anion transport through the plasma membrane of the retinal pigment epithelium (RPE). To date, while no treatment exists a better understanding of BEST1-related pathogenesis may help to define therapeutic targets. Here, we systematically characterize functional consequences of mutant BEST1 in thirteen RPE patient cell lines differentiated from human induced pluripotent stem cells (hiPSCs). Both BD and ARB hiPSC-RPEs display a strong reduction of BEST1-mediated anion transport function compared to control, while ADVIRC mutations trigger an increased anion permeability suggesting a stabilized open state condition of channel gating. Furthermore, BD and ARB hiPSC-RPEs differ by the degree of mutant protein turnover and by the site of subcellular protein quality control with adverse effects on lysosomal pH only in the BD-related cell lines. The latter finding is consistent with an altered processing of catalytic enzymes in the lysosomes. The present study provides a deeper insight into distinct molecular mechanisms of the three bestrophinopathies facilitating functional categorization of the more than 300 known BEST1 mutations that result into the distinct retinal phenotypes. MDPI 2020-02-26 /pmc/articles/PMC7084480/ /pubmed/32111077 http://dx.doi.org/10.3390/ijms21051597 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nachtigal, Anna-Lena Milenkovic, Andrea Brandl, Caroline Schulz, Heidi L. Duerr, Lisa M. J. Lang, Gabriele E. Reiff, Charlotte Herrmann, Philipp Kellner, Ulrich Weber, Bernhard H.F. Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies |
title | Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies |
title_full | Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies |
title_fullStr | Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies |
title_full_unstemmed | Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies |
title_short | Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies |
title_sort | mutation-dependent pathomechanisms determine the phenotype in the bestrophinopathies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084480/ https://www.ncbi.nlm.nih.gov/pubmed/32111077 http://dx.doi.org/10.3390/ijms21051597 |
work_keys_str_mv | AT nachtigalannalena mutationdependentpathomechanismsdeterminethephenotypeinthebestrophinopathies AT milenkovicandrea mutationdependentpathomechanismsdeterminethephenotypeinthebestrophinopathies AT brandlcaroline mutationdependentpathomechanismsdeterminethephenotypeinthebestrophinopathies AT schulzheidil mutationdependentpathomechanismsdeterminethephenotypeinthebestrophinopathies AT duerrlisamj mutationdependentpathomechanismsdeterminethephenotypeinthebestrophinopathies AT langgabrielee mutationdependentpathomechanismsdeterminethephenotypeinthebestrophinopathies AT reiffcharlotte mutationdependentpathomechanismsdeterminethephenotypeinthebestrophinopathies AT herrmannphilipp mutationdependentpathomechanismsdeterminethephenotypeinthebestrophinopathies AT kellnerulrich mutationdependentpathomechanismsdeterminethephenotypeinthebestrophinopathies AT weberbernhardhf mutationdependentpathomechanismsdeterminethephenotypeinthebestrophinopathies |